_version_ 1785090463852658688
author Ondrisova, Laura
Seda, Vaclav
Hoferkova, Eva
Chiodin, Giorgia
Hlavac, Krystof
Kostalova, Lenka
Filip, Daniel
Faria Zeni, Pedro
Panovska, Anna
Plevova, Karla
Pospisilova, Sarka
Simkovic, Martin
Vrbacky, Filip
Lysak, Daniel
Fernandes, Stacey M.
Davids, Matthew S.
Maiques-Diaz, Alba
Charalampopoulou, Stella
Martin-Subero, Jose I
Brown, Jennifer R
Doubek, Michael
Forconi, Francesco
Mayer, Jiri
Mraz, Marek
author_facet Ondrisova, Laura
Seda, Vaclav
Hoferkova, Eva
Chiodin, Giorgia
Hlavac, Krystof
Kostalova, Lenka
Filip, Daniel
Faria Zeni, Pedro
Panovska, Anna
Plevova, Karla
Pospisilova, Sarka
Simkovic, Martin
Vrbacky, Filip
Lysak, Daniel
Fernandes, Stacey M.
Davids, Matthew S.
Maiques-Diaz, Alba
Charalampopoulou, Stella
Martin-Subero, Jose I
Brown, Jennifer R
Doubek, Michael
Forconi, Francesco
Mayer, Jiri
Mraz, Marek
author_sort Ondrisova, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-10428416
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284162023-08-17 S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY Ondrisova, Laura Seda, Vaclav Hoferkova, Eva Chiodin, Giorgia Hlavac, Krystof Kostalova, Lenka Filip, Daniel Faria Zeni, Pedro Panovska, Anna Plevova, Karla Pospisilova, Sarka Simkovic, Martin Vrbacky, Filip Lysak, Daniel Fernandes, Stacey M. Davids, Matthew S. Maiques-Diaz, Alba Charalampopoulou, Stella Martin-Subero, Jose I Brown, Jennifer R Doubek, Michael Forconi, Francesco Mayer, Jiri Mraz, Marek Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428416/ http://dx.doi.org/10.1097/01.HS9.0000967480.82284.34 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Ondrisova, Laura
Seda, Vaclav
Hoferkova, Eva
Chiodin, Giorgia
Hlavac, Krystof
Kostalova, Lenka
Filip, Daniel
Faria Zeni, Pedro
Panovska, Anna
Plevova, Karla
Pospisilova, Sarka
Simkovic, Martin
Vrbacky, Filip
Lysak, Daniel
Fernandes, Stacey M.
Davids, Matthew S.
Maiques-Diaz, Alba
Charalampopoulou, Stella
Martin-Subero, Jose I
Brown, Jennifer R
Doubek, Michael
Forconi, Francesco
Mayer, Jiri
Mraz, Marek
S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title_full S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title_fullStr S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title_full_unstemmed S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title_short S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY
title_sort s142: foxo1-rictor axis induces adaptive increase in akt activity during bcr inhibitor therapy in cll: implications for combination therapy
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428416/
http://dx.doi.org/10.1097/01.HS9.0000967480.82284.34
work_keys_str_mv AT ondrisovalaura s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT sedavaclav s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT hoferkovaeva s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT chiodingiorgia s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT hlavackrystof s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT kostalovalenka s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT filipdaniel s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT fariazenipedro s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT panovskaanna s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT plevovakarla s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT pospisilovasarka s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT simkovicmartin s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT vrbackyfilip s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT lysakdaniel s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT fernandesstaceym s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT davidsmatthews s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT maiquesdiazalba s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT charalampopouloustella s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT martinsuberojosei s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT brownjenniferr s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT doubekmichael s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT forconifrancesco s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT mayerjiri s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy
AT mrazmarek s142foxo1rictoraxisinducesadaptiveincreaseinaktactivityduringbcrinhibitortherapyincllimplicationsforcombinationtherapy